Calitatea vieţii la pacienţii cu artrită psoriazică -  provocare pentru practicieni
Închide
Conţinutul numărului revistei
Articolul precedent
Articolul urmator
1029 32
Ultima descărcare din IBN:
2024-03-01 18:15
Căutarea după subiecte
similare conform CZU
616.72-002:616.517 (9)
Patologia organelor de locomoţie. Sistemul osos şi locomotor (469)
Piele. Tegumente în general. Dermatologie clinică. Tulburări cutanate (210)
SM ISO690:2012
ȘALARU, Virginia, ROTARU, Tatiana, GODOROJA, Doina, MAZUR-NICORICI, Lucia, SADOVICI-BOBEICA, Victoria, MAZUR, Minodora. Calitatea vieţii la pacienţii cu artrită psoriazică -  provocare pentru practicieni. In: Sănătate Publică, Economie şi Management în Medicină , 2017, nr. 3(73), pp. 166-167. ISSN 1729-8687.
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
Sănătate Publică, Economie şi Management în Medicină
Numărul 3(73) / 2017 / ISSN 1729-8687 /ISSNe 2587-3873

Calitatea vieţii la pacienţii cu artrită psoriazică -  provocare pentru practicieni

Quality of life in patients with psoriatic arthritis – challenge for practitioners

CZU: 616.72-002:616.517

Pag. 166-167

Șalaru Virginia1, Rotaru Tatiana2, Godoroja Doina1, Mazur-Nicorici Lucia1, Sadovici-Bobeica Victoria1, Mazur Minodora1
 
1 Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“,
2 IMSP Institutul de Cardiologie
 
 
Disponibil în IBN: 3 noiembrie 2017


Rezumat

Psoriatic arthritis (PsA) is a unique inflammatory musculoskeletal disorder associated with psoriasis. Psoriasis as well as psoriatic arthritis can have a large impact on a patient’s quality of life. However the burden of disease is not well understood in psoriatic arthritis. The objective of this study was to evaluate disease characteristics and psoriasis-related quality of life (QoL) in patients with PsA. Consecutive patients with PsA (CASPAR criteria) completed VAS pain, EuroQoL-5 Domains Questionnaire and Dermatology Quality Live Index. The mean scores were compared and correlated with clinical and socio-demographic characteristics. The results showed that the patients with PsA have a poorer QoL, mainly determined by the extent of skin lesions and pain intensity.

Cerif XML Export

<?xml version='1.0' encoding='utf-8'?>
<CERIF xmlns='urn:xmlns:org:eurocris:cerif-1.5-1' xsi:schemaLocation='urn:xmlns:org:eurocris:cerif-1.5-1 http://www.eurocris.org/Uploads/Web%20pages/CERIF-1.5/CERIF_1.5_1.xsd' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' release='1.5' date='2012-10-07' sourceDatabase='Output Profile'>
<cfResPubl>
<cfResPublId>ibn-ResPubl-55631</cfResPublId>
<cfResPublDate>2017-07-01</cfResPublDate>
<cfVol>73</cfVol>
<cfIssue>3</cfIssue>
<cfStartPage>166</cfStartPage>
<cfISSN>1729-8687</cfISSN>
<cfURI>https://ibn.idsi.md/ro/vizualizare_articol/55631</cfURI>
<cfTitle cfLangCode='RO' cfTrans='o'>Calitatea vieţii la pacienţii cu artrită psoriazică -&nbsp; provocare pentru practicieni</cfTitle>
<cfAbstr cfLangCode='EN' cfTrans='o'><p><em>Psoriatic arthritis (PsA) is a unique inflammatory musculoskeletal disorder associated with psoriasis. Psoriasis as well as psoriatic arthritis can have a large impact on a patient&rsquo;s quality of life. However the burden of disease is not well understood in psoriatic arthritis. The objective of this study was to evaluate disease characteristics and psoriasis-related quality of life (QoL) in patients with PsA. Consecutive patients with PsA (CASPAR criteria) completed VAS pain, EuroQoL-5 Domains Questionnaire and Dermatology Quality Live Index. The mean scores were compared and correlated with clinical and socio-demographic characteristics. The results showed that the patients with PsA have a poorer QoL, mainly determined by the extent of skin lesions and pain intensity.</em></p></cfAbstr>
<cfResPubl_Class>
<cfClassId>eda2d9e9-34c5-11e1-b86c-0800200c9a66</cfClassId>
<cfClassSchemeId>759af938-34ae-11e1-b86c-0800200c9a66</cfClassSchemeId>
<cfStartDate>2017-07-01T24:00:00</cfStartDate>
</cfResPubl_Class>
<cfResPubl_Class>
<cfClassId>e601872f-4b7e-4d88-929f-7df027b226c9</cfClassId>
<cfClassSchemeId>40e90e2f-446d-460a-98e5-5dce57550c48</cfClassSchemeId>
<cfStartDate>2017-07-01T24:00:00</cfStartDate>
</cfResPubl_Class>
<cfPers_ResPubl>
<cfPersId>ibn-person-45345</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2017-07-01T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-43106</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2017-07-01T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-54354</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2017-07-01T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-27145</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2017-07-01T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-40067</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2017-07-01T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-11763</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2017-07-01T24:00:00</cfStartDate>
</cfPers_ResPubl>
</cfResPubl>
<cfPers>
<cfPersId>ibn-Pers-45345</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-45345-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2017-07-01T24:00:00</cfStartDate>
<cfFamilyNames>Șalaru</cfFamilyNames>
<cfFirstNames>Virginia</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-43106</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-43106-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2017-07-01T24:00:00</cfStartDate>
<cfFamilyNames>Rotaru</cfFamilyNames>
<cfFirstNames>Tatiana</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-54354</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-54354-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2017-07-01T24:00:00</cfStartDate>
<cfFamilyNames>Godoroja</cfFamilyNames>
<cfFirstNames>Doina</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-27145</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-27145-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2017-07-01T24:00:00</cfStartDate>
<cfFamilyNames>Mazur-Nicorici</cfFamilyNames>
<cfFirstNames>Lucia</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-40067</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-40067-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2017-07-01T24:00:00</cfStartDate>
<cfFamilyNames>Sadovici-Bobeica</cfFamilyNames>
<cfFirstNames>Victoria</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-11763</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-11763-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2017-07-01T24:00:00</cfStartDate>
<cfFamilyNames>Mazur</cfFamilyNames>
<cfFirstNames>Minodora</cfFirstNames>
</cfPersName_Pers>
</cfPers>
</CERIF>